Adrian F. Hernandez
Duke University(US)Council for British Research in the Levant(GB)Clinical Research Institute(US)Smart Material (Germany)(DE)Duke Medical Center(US)Duke University Health System(US)Duke University Hospital(US)The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, Diabetes Treatment and Management, Acute Ischemic Stroke Management
Most-Cited Works
- → Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)2,473 cited
- → 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure(2022)2,381 cited
- → Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes(2017)2,088 cited
- → Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial(2018)1,726 cited
- → Diuretic Strategies in Patients with Acute Decompensated Heart Failure(2011)1,653 cited
- → Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction(2020)1,247 cited